Francisco Bustamante, President, Lifeline Cell Technology Mr. Bustamante has over 18 years of experience in the operations of biotechnology companies. His experience includes senior management positions in the areas of manufacturing, procurement, planning, warehousing, distribution and project management. He possesses experience in the manufacture and logistics of cell culture products, biological instruments, molecular biology kits and diagnostics. He has led key projects in the areas of MRP implementation, ISO compliance, product development, product transfer, and change leadership to name a few. His industry experience includes Clonetics, BioWhittaker, Cambrex, Digene and Meso Scale Diagnostics. Mr. Bustamante received his B.S. degree in Biology from the University of San Diego and an M.B.A. from Frostburg State University, Frostburg, Maryland.
Alexa Dillberger, Senior Vice President, Lifeline Cell Technology Ms. Dillberger has over 26 years experience in the commercialization and sales of research products to researchers in the biotechnology industry, including 12 years leading sales for normal human cell and media products. Ms. Dillberger is expert in the isolation, purification and manufacture of specific human cells from tissue. She is experienced in running cGMP laboratories for cell culture. Her technical, manufacturing and sales background make her aware of the issues that are important to researchers in the field and uniquely able to provide the technical service that is so important to make Lifeline a resource to its customers.
Jeremy Hammond, Co-founder and Director of Quality Control Mr. Hammond has over 20 years of experience developing human cell based products and the quality control systems critical for their manufacture. He created and implemented the quality control systems that were responsible for making Clonetics products world renown for consistency and reproducibility. These quality control systems are the standard for companies currently manufacturing human cell based products. Mr. Hammond is expert in the field of both serum-containing and serum-free media formulations and in the purification of human cells, fields critical for therapeutic applications of cell culture technology.